Search - tctmd.com

Displaying 21 - 40 of 46

Sort: Relevancy | Date

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Industry News

Boston Scientific Initiates Study Of Promus PREMIER™ Coronary Stent System In Underserved Patient Populations

October 20, 2014

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Industry News

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

September 02, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Industry News

Abbott to Acquire Veropharm

June 23, 2014

News Industry News

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

May 23, 2014

News Industry News

ANTI-CLOTTING AGENT HELPS REDUCE THE INCIDENCE AND IMPACT OF STENT THROMBOSIS DURING PERCUTANEOUS CORONARY INTERVENTION

March 27, 2014

News Industry News

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

January 08, 2014

News Industry News

Novel Study Finds Using Radial Versus Femoral Access During Cardiac Catheterization May Have Benefits in Women

October 29, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Industry News

Northwestern Medicine Researchers Investigate New Stent Technology to Treat Coronary Artery Disease

August 16, 2013

News Industry News

FDA Accepts the Filing of The Medicines Company's New Drug Application for Intravenous Antiplatelet Agent Cangrelor

July 01, 2013

News Industry News

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant Hypertension

May 23, 2013

News Industry News

Twelve Rising Interventional Cardiologists Selected for First-of-its-Kind Emerging Leader Mentorship Program

February 25, 2013

News Industry News

Abbott Initiates Clinical Trial of Absorb™ in the United States

January 07, 2013

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Industry News

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study

August 15, 2011

News Industry News

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

August 01, 2011

Advertisement

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

Boston Scientific Initiates Study Of Promus PREMIER™ Coronary Stent System In Underserved Patient Populations

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

Abbott to Acquire Veropharm

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

ANTI-CLOTTING AGENT HELPS REDUCE THE INCIDENCE AND IMPACT OF STENT THROMBOSIS DURING PERCUTANEOUS CORONARY INTERVENTION

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

Novel Study Finds Using Radial Versus Femoral Access During Cardiac Catheterization May Have Benefits in Women

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

Northwestern Medicine Researchers Investigate New Stent Technology to Treat Coronary Artery Disease

FDA Accepts the Filing of The Medicines Company's New Drug Application for Intravenous Antiplatelet Agent Cangrelor

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant Hypertension

Twelve Rising Interventional Cardiologists Selected for First-of-its-Kind Emerging Leader Mentorship Program

Abbott Initiates Clinical Trial of Absorb™ in the United States

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

Medtronic Starts Landmark Study of Hypertension Treatment

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content